Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

SZSE:300357.SZ

26.98 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 228.472195.156300.981210.8214.957174.4287.496203.156183.14195.836311.276191.317197.588187.97272.117182.95164.654145.149231.631149.153110.276139.354225.662136.253138.084115.051166.984111.775106.93491.954128.4984.03381.173.619105.05164.29869.11764.86784.45558.69659.08858.39875.82753.3751.91647.14158.8244.59543.05438.88753.032
Cost of Revenue 11.9710.17512.94720.97310.4169.22611.4839.8589.62311.90114.0958.3278.1928.94110.4188.1226.9576.1248.2589.3064.8495.4017.7484.7914.9125.03210.1486.257.0885.2723.7952.7142.3041.9143.6413.0972.9043.0323.843.6282.6032.1823.2952.3771.8781.8382.0291.7631.7447.5590
Gross Profit 216.502184.981288.034189.827204.541165.173276.013193.298173.517183.934297.182182.99189.395179.029261.699174.829157.697139.025223.372139.847105.427133.953217.914131.461133.172110.019156.837105.52599.84686.682124.69481.31978.79671.706101.4161.20266.21361.83580.61555.06856.48556.21672.53250.99350.03845.30356.79142.83241.3131.32853.032
Gross Profit Ratio 0.9480.9480.9570.9010.9520.9470.960.9510.9470.9390.9550.9560.9590.9520.9620.9560.9580.9580.9640.9380.9560.9610.9660.9650.9640.9560.9390.9440.9340.9430.970.9680.9720.9740.9650.9520.9580.9530.9550.9380.9560.9630.9570.9550.9640.9610.9660.960.9590.8061
Reseach & Development Expenses 29.64232.02128.60924.3330.56433.70228.90325.17824.41335.74527.65221.81726.8527.02122.15818.59720.15120.38419.59613.97310.92215.01412.1027.6156.4394.4423.2543.2712.51110.0021.9563.44509.23707.656010.30107.363010.99707.063010.08806.892000
General & Administrative Expenses 16.858-38.49846.858-11.24716.458-31.36936.75-8.92212.80413.133.038-9.20810.892-26.56432.629-8.92111.54-17.04510.213-4.9437.584-12.8137.573-3.5746.948-14.7089.378-4.4488.831-15.8268.578-2.5267.038-17.2717.696-5.2977.685-14.4717.459-4.6687.231-15.4126.423-6.16613.669-12.735.039-4.0526.12700
Selling & Marketing Expenses 92.234-62.426178.04682.47680.96280.54795.32777.6569.64383.81893.45367.47867.06276.61578.96465.41761.11363.34764.37149.41246.52558.81766.35850.12648.40151.70547.18536.17233.22637.86434.79828.34427.88332.01830.95825.66825.85325.89626.28722.26721.59524.40723.95919.7720.55421.15320.03518.20816.3300
SG&A 109.092-100.924225.59394.91599.30249.178132.07768.72882.44893.999126.49158.2777.95450.051111.59356.49672.65346.30274.58444.46954.10946.00473.93146.55255.34936.99756.56331.72442.05722.03843.37525.81834.92114.74638.65420.37133.53811.42633.74617.59928.8268.99530.38213.60434.2238.42325.07414.15622.45700
Other Expenses -7.037200.953-109.912-1.727-0.210.108-0.0140.7360.11534.358-22.5728.677-12.982-1.9150.1481.938-0.078-9.2248.2370.8591.226-1.2231.7161.8370.0110.0941.0390.0320.4610.4750.3251.6970.2490.0320.2450.0410.0541.3390.4052.740.0451.8320.2513.7350.6940.3250.5060.2280.401-17.623-29.088
Operating Expenses 131.698132.051144.29119.245129.866132.558138.785115.865106.976164.102131.5788.76491.822113.949115.15794.88683.281.49695.06570.94365.46183.79887.48264.74562.17167.65860.20248.34442.44447.33743.82338.0935.20144.32239.04533.35433.81534.57634.09627.57429.0730.73130.69425.94234.59430.01326.07125.13823.165-17.623-29.088
Operating Income 84.80452.931143.74470.58274.67544.386140.87785.16774.54319.833169.342102.079104.95373.944151.29786.70480.96165.843134.03474.89246.7560.252133.46872.62177.03450.5599.19160.92360.69143.30881.99446.03244.88930.3261.96330.3633.32329.94946.25829.14328.77229.83241.41926.21214.94717.07428.91717.40118.29913.70523.944
Operating Income Ratio 0.3710.2710.4780.3350.3470.2550.490.4190.4070.1010.5440.5340.5310.3930.5560.4740.4920.4540.5790.5020.4240.4320.5910.5330.5580.4390.5940.5450.5680.4710.6380.5480.5540.4120.590.4720.4820.4620.5480.4970.4870.5110.5460.4910.2880.3620.4920.390.4250.3520.452
Total Other Income Expenses Net -0.845-1.393-0.71812.121-0.210.108-0.0140.7360.1520.3990.4520.5221.168-1.9150.1481.938-0.078-9.2248.2370.8591.226-1.2231.7161.8370.0110.0941.0390.0320.4610.5820.3251.6770.249-0.865-3.3050.0320.0041.3350.4012.7140.0441.8020.2393.7350.6920.3220.4930.2030.5552.2160.386
Income Before Tax 83.95951.538143.02683.31888.2344.493140.86485.90374.69520.231169.794102.6106.12272.029151.44588.64280.88256.619142.2775.75147.97659.029135.18474.45877.04550.644100.2360.95561.15343.88982.23647.70945.13529.45558.65830.39333.32731.28346.65931.85728.81631.63441.65829.94815.63917.39629.4117.60418.715.92124.331
Income Before Tax Ratio 0.3670.2640.4750.3950.410.2550.490.4230.4080.1030.5450.5360.5370.3830.5570.4850.4910.390.6140.5080.4350.4240.5990.5460.5580.440.60.5450.5720.4770.640.5680.5570.40.5580.4730.4820.4820.5520.5430.4880.5420.5490.5610.3010.3690.50.3950.4340.4090.459
Income Tax Expense 12.4089.69723.1513.99613.888.75322.79411.2117.6753.42427.11915.32717.15312.03427.24514.27413.15510.27222.95711.9167.7479.22921.05311.24411.5717.90815.0428.9699.1986.27412.4777.1866.9282.83310.2084.744.854.7326.7244.6664.6777.1755.93.9572.2962.9174.8572.1942.5932.5523.591
Net Income 74.34245.568123.02372.02477.20740.037121.54378.12670.47821.557146.13589.34691.73563.398127.27676.86270.45449.317122.07565.68641.36951.715116.10464.34166.13843.54585.39951.98651.95437.61569.75840.52238.20826.62248.4525.65328.47726.55239.93527.16524.16924.45835.75725.9913.34914.4824.55515.41516.11513.36820.74
Net Income Ratio 0.3250.2330.4090.3420.3590.230.4230.3850.3850.110.4690.4670.4640.3370.4680.420.4280.340.5270.440.3750.3710.5150.4720.4790.3780.5110.4650.4860.4090.5430.4820.4710.3620.4610.3990.4120.4090.4730.4630.4090.4190.4720.4870.2570.3070.4170.3460.3740.3440.391
EPS 0.140.0870.230.140.150.0770.230.150.130.0410.280.170.180.120.240.150.130.0940.230.130.0790.0990.220.120.130.0830.160.180.0990.0720.130.0790.0740.0510.0930.050.0560.0510.0770.0520.0460.0460.0680.0490.040.0310.0530.0330.0350.0290.045
EPS Diluted 0.140.0870.230.140.150.0770.230.150.130.0410.280.170.180.120.240.150.130.0940.230.130.0790.0990.220.120.130.0830.160.180.0990.0720.130.0790.0740.0510.0930.050.0560.0510.0770.0520.0460.0460.0680.0490.040.0310.0530.0330.0350.0290.045
EBITDA 84.17951.702143.30696.492101.42356.96154.60295.53283.83133.915178.299110.518106.20280.708158.65295.33987.5957.529146.57579.67651.90162.088138.24376.82279.40942.36198.96357.18158.3839.34580.87143.22944.57727.7967.61127.84733.49627.25847.86627.49427.41523.98843.33825.05116.48715.01932.83517.69318.145-44.90853.032
EBITDA Ratio 0.3680.2650.4760.4580.4720.3270.5380.470.4580.1730.5730.5780.5370.4290.5830.5210.5320.3960.6330.5340.4710.4460.6130.5640.5750.3680.5930.5120.5460.4280.6290.5140.550.3770.6440.4330.4850.420.5670.4680.4640.4110.5720.4690.3180.3190.5580.3970.421-1.1551